Considered the most advanced center of research for medicinal cannabis in the world, Israel opens its doors in welcome of foreign doctors. The government has launched the first nonnative specialization course. If spots are filled quickly, classes are due for an early start in November, if not, in January.
“We want to transform students into new teachers so that information can exponentially spread throughout the world,” says Yuval Lanschaft, 57, director of the IMCA (Israeli Medical Cannabis Agency), a branch of the country’s Department of Health. He was a health reform architect for medical cannabis to be regularized in 2018.
According to Lanschaft, “the doctors need to know the mechanism action of CBD (the therapeutical substance of Cannabis) in the body. Only with specific information, they are able to recognize patients with an indication for therapy and prescribe medication.
The event consists of a five-day immersion course. Each with an eight-hour class load. The first four days are to be packed with theory, and the last, touring plantations and greenhouses where cannabis is cloned. Students will be able to watch the entirety of the productive process. “We have 10 thousand cloned plants.” According to Lanschaft, the technical advantage lies in producing buds with the same concentrations of CBD.